Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

Clinical trial NCT01889160 · COMPLETED

Trial details

NCT number: NCT01889160
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and Tmax

Start date: 2013-07-01
Primary completion: 2013-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.